The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma

NCT06277791 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Clinical IVb Stage Oral Squamous Cell Carcinomas Patients

Interventions

DRUG: Adebrelimab

Sponsor

Hospital of Stomatology, Wuhan University